Company Benefit

Employee Benefit & Consumer Driven Healthcare

Please Share the News & Follow Us.

RSS
Follow by Email
Facebook
fb-share-icon
Twitter
Tweet
LinkedIn
Share
  • Home
  • News/Articles Library
  • Benefit Plan Types
    • Flexible Benefit, Cafeteria Plans, & Tax Advantaged Plan Options
    • Health Reimbursement Arrangements (HRAs)
    • Health Savings Accounts (HSA) Implementation
    • Commuter Company Benefits
    • Employee Benefit Plan Type Comparison
    • Employer Benefit Plan Eligibility Requirements
  • Contact Us

Israeli study shows Pfizer vaccine 94 percent effective

02/21/2021 By Benefit News

COVID-19
Credit: Pixabay/CC0 Public Domain

Israel’s largest healthcare provider said Sunday a study of more than half a million fully vaccinated Israelis indicated the Pfizer/BioNTech jab gave 94 percent protection against COVID-19.

Clalit Health Services said that in a groundbreaking project its researchers tested 600,000 subjects who had received the recommended two doses of the US-German Pfizer/BioNTech vaccine and the same number of people who had not been innoculated.

“There was a 94 percent reduction in the rate of symptomatic infection and a 92 percent decrease in the rate of serious illness compared to 600,000 similar (subjects) who were not vaccinated,” Clalit said in a Hebrew-language statement.

“Vaccine efficacy is maintained in all age groups, including those aged 70+,” it added.

Israel’s mass vaccination campaign has seen 3.8 million people receive a first dose, while 2.4 million have also received a second shot.

The country of nine million people, which is currently easing restrictions imposed during its third nationwide lockdown, is aiming to vaccinate everyone over the age of 16 by the end of March.

“The publication of preliminary results at this stage is intended to emphasise to the unvaccinated population that the vaccine is highly effective and prevents serious morbidity,” Clalit said Sunday.

It added that the study covered people who had received the second shot at least seven days before being tested, and would be expanded in future.

“With each additional week that passes, we will be able to make the assessment more accurate.”

Accuracy would improve as subjects are tested after 14 days or more from the second dose, it said.

Israel has so far relied on only the Pfizer/BioNTech vaccine, although it holds a small stock of the vaccine developed by US biotech firm Moderna.

Israel secured plentiful supplies of vaccine from Pfizer after striking a data-sharing deal with the US manufacturer.

The agreement stipulates that the Jewish state, which has one of the world’s most sophisticated medical data systems, will share real-time information with Pfizer on the vaccine‘s impact, including on progress towards herd immunity.

Clalit is the biggest of Israel’s four health service providers, which collectively provide healthcare to the entire population.

They are directly responsible for vaccinations and collecting data on their impact.



© 2021 AFP

Citation:
Israeli study shows Pfizer vaccine 94 percent effective (2021, February 14)
retrieved 21 February 2021
from https://medicalxpress.com/news/2021-02-israeli-pfizer-vaccine-percent-effective.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Read More

facebook Share on Facebook
Twitter Tweet
Follow Connect on LinkedIn
custom Share
custom Share
custom Share
custom Share
custom Share

Filed Under: Benefits Updates

Get alerts & updates via. email.
Error occured. Please confirm your data and submit again:
companybenefit.com virus updates

Breaking Health Updates:

UK’s Integumen Unveils Prototype COVID-19 Breath Test

LONDON (Reuters) - Integumen, a British … [More...]

Becton Dickinson Reaches $60 Million Settlement Over Pelvic Mesh Devices

NEW YORK (Reuters) - Becton Dickinson and Co … [More...]

Birx: Not Considering Leaving Coronavirus Task Force

Editor's note: Find the latest COVID-19 news … [More...]

COVID-19 LIVE UPDATES: Kansas reports 262 new cases, while Missouri adds 211 on Wednesday – KMBC Kansas City

The Kansas City metro has emerged from … [More...]

Experts suggest improving ventilation may reduce coronavirus spread – CBS News

A study finds that improving ventilation can … [More...]

All Coronavirus Posts:

Robot That Can Perform ‘Supermicrosurgery’ Passes First Test in Humans – Gizmodo

The MUSA robotic platform, developed by MicroSure. Image: MicroSureA surgical robot capable of reconnecting vessels with diameters as tiny as 0.3 millimeters has been tested on human patients, and the results are promising. New research published in Nature Communications describes MUSA—the first robotic system designed exclusively for performing reconstructive supermicrosurgery. Using the system, surgeons were able to reconnect vessels with diameters between 0.3 and 0.8 … [Read More...]

Updates & Alerts

Get alerts & updates via. email.
Error occured. Please confirm your data and submit again:

Are you Aware of Transit Benefits?

Commuter Company Benefits

Transit / Transportation Company Benefit Up to $260/month* for transit benefit expenses The Commuter Transit Account / Transportation company benefit is a pre-tax benefit account used to pay for public transit—including train, subway, light rail, bus, and ferry—as part of

breakdown of benefit options:

Employee Benefit Plan Type Comparison

Flexible Spending Account, Health Reimbursement Arraignments, & Health Savings Account Comparison The chart below is a brief comparison of the various components of each of these important health care options. Description FSA HRA HSA History IRS Code … more

Savings

Employee Benefits and Tax Savings

Benefit to Employee HOW DOES THE EMPLOYEE BENEFIT? The employee can choose to participate in the plan or not. If the employee participates in the plan part of his/her taxable wage is converted into tax-free benefits. This can be a big tax savings for the employee and … more

Copyright © 2021 · CompanyBenefit.com · Log in

Terms and Conditions - Privacy Policy